Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:84-89
Published online before print September 30, 2004, doi: 10.1161/01.ATV.0000146814.81581.68
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/1/84    most recent
01.ATV.0000146814.81581.68v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bulin, C.
Right arrow Articles by Fischer, J.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bulin, C.
Right arrow Articles by Fischer, J.W.
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Smooth muscle proliferation and differentiation
Right arrow Arterial thrombosis
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:84.)
© 2005 American Heart Association, Inc.


Vascular Biology

Differential Effects of Vasodilatory Prostaglandins on Focal Adhesions, Cytoskeletal Architecture, and Migration in Human Aortic Smooth Muscle Cells

C. Bulin; U. Albrecht; J.G. Bode; A.-A. Weber; K. Schrör; B. Levkau; J.W. Fischer

From the Molekulare Pharmakologie (C.B., J.W.F.), Institut für Pharmakologie und Klinische Pharmakologie (A.-A.W., K.S.), Klinik für Gastroenterologie, Hepatologie und Infektiologie (U.A., J.G.B.), Heinrich Heine Universität Düsseldorf; and the Institut für Pathophysiologie, Universitätsklinikum Essen (B.L.), Germany.

Correspondence to Jens W. Fischer, Molecular Pharmacology, Institut für Pharmakologie and Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstrasse 5, D-40225 Düsseldorf. E-mail jens.fischer{at}uni-duesseldorf.de

Objective— Cyclooxygenases 1 and 2 are expressed in atherosclerotic arteries, and local generation of prostacyclin and prostaglandin E2 (PGE2) occurs. However, the role of cyclooxygenases and individual prostaglandins during plaque progression is currently uncertain. The present study characterizes the effect of vasodilatory prostaglandins on morphology, focal adhesion (FA) function, and migration in human aortic smooth muscle cells (SMCs).

Methods and Results— The stable prostacyclin analog iloprost transiently induced: (1) disassembly of FA and stress fibers, (2) partial retraction and rounding of SMCs, (3) hypophosphorylation of FA kinase (FAK) and paxillin, and (4) inhibition of platelet-derived growth factor-BB–induced migration. Inhibition of FAK phosphorylation and morphological changes were mimicked by forskolin, inhibited by H89, and prevented by the protein tyrosine phosphatase inhibitor vanadate and by calpeptin. PGE2 was by far less efficient with respect to all parameters investigated. This difference correlated with the respective cAMP induction in response to iloprost and PGE2.

Conclusion— Inhibition of FAK phosphorylation and FA function is a new target of vasodilatory prostaglandins, which might be causally involved in the antimigratory effects of prostaglandins. Importantly, prostacyclin analogs and PGE2 differ dramatically with respect to dephosphorylation of FAK and inhibition of migration, which might be of relevance for their respective functions in atherosclerosis.

The present study identifies focal adhesions (FAs) as a target of prostaglandin signaling in human vascular smooth muscle cells. Specifically, it is demonstrated that vasodilatory prostaglandins inhibit in a cAMP-dependent manner FA–kinase phosphorylation, which is associated with disassembly of FA, actin cytoskeleton, and reduced VSMC migration.


Key Words: focal adhesion kinase • extracellular matrix • prostaglandins • atherosclerosis




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Pape, B. H. Rauch, A. C. Rosenkranz, G. Kaber, and K. Schror
Transcriptional Inhibition of Protease-Activated Receptor-1 Expression by Prostacyclin in Human Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. A. Bondesen, K. A. Jones, W. C. Glasgow, and G. K. Pavlath
Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion
FASEB J, October 1, 2007; 21(12): 3338 - 3345.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Thomas, M. Peters-Golden, E. S. White, V. J. Thannickal, and B. B. Moore
PGE2 inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L417 - L428.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. H. Rauch, G. A. Scholz, D. Baumgartel-Allekotte, P. Censarek, J. W. Fischer, A.-A. Weber, and K. Schror
Cholesterol Enhances Thrombin-Induced Release of Fibroblast Growth Factor-2 in Human Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): e20 - e25.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Swaney, H. H. Patel, U. Yokoyama, B. P. Head, D. M. Roth, and P. A. Insel
Focal Adhesions in (Myo)fibroblasts Scaffold Adenylyl Cyclase with Phosphorylated Caveolin
J. Biol. Chem., June 23, 2006; 281(25): 17173 - 17179.
[Abstract] [Full Text] [PDF]